ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
08 mars 2023 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director
07 mars 2023 03h00 HE
|
MitoRx Therapeutics
OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...
Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
02 mars 2023 09h00 HE
|
Next Move Strategy Consulting
New York, March 02, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 billion in 2021, and is projected to...
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer
02 mars 2023 04h00 HE
|
SiSaf Ltd
GUILDFORD, United Kingdom, March 02, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announces its collaboration with the University of Leipzig, Germany, to develop...
Yasheng's AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development
24 févr. 2023 03h30 HE
|
Yasheng Group
San Jose, California, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Yasheng's AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development SAN JOSE, CA--(February 24, 2023) - Yasheng Group, (OTC:...
Derm-Biome Pharmaceuticals to Present at the 2023 OBIO Investment Summit on February 10, 2023
07 févr. 2023 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that it has...
Endogena Therapeutics Receives US FDA Fast Track Designation for EA-2353 for the Treatment of Retinitis Pigmentosa
06 févr. 2023 07h00 HE
|
Endogena
SAN FRANCISCO, TORONTO and ZÜRICH, Switzerland, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Endogena Therapeutics Inc., a clinical-stage biotech company focused on the development of endogenous...
Vaccines & Therapeutics Market Size in 2023 (New Report): Manufacturers Data, Opportunity, Import Export Scenario, Application, Showing Impressive Growth | No. of pages: 82
10 janv. 2023 05h16 HE
|
Proficient Market Insights
pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Vaccines & Therapeutics Market" research report focus on overall information that can help to take decisions on current market situation. Vaccines &...
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference
05 janv. 2023 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare...
Biopharmaceutical Executive Eric Strati joins Gift of Life Biologics as Chief Executive Officer
02 janv. 2023 10h00 HE
|
Gift of Life Marrow Registry
BOCA RATON, Fla., Jan. 02, 2023 (GLOBE NEWSWIRE) -- Gift of Life Biologics announced today that accomplished biopharmaceutical leader Eric Strati, Pharm.D. MBA has joined the firm as its Chief...